Literature DB >> 1848609

Neurologic and psychiatric manifestations of HIV disease.

H Hollander1.   

Abstract

Neuropsychiatric problems have assumed an increasingly prominent role in HIV-infected individuals. Disease occurs at all levels of the central and peripheral nervous systems by a variety of mechanisms. The AIDS dementia complex is the prototypical example of "direct" effects of HIV on the neuraxis, while infections such as toxoplasmosis and cryptococcal meningitis are complications of HIV-induced immunosuppression. Neurologic manifestations vary in frequency depending upon the overall stage of HIV disease; diagnostic difficulties may be encountered because of HIV's effect on cerebrospinal fluid parameters. The uncertainties of management of neurosyphilis in this setting provide and example of these problems. As is the case with other organ systems, the main goal of neurodiagnostic efforts is to find the increasing number of treatable components of neuropsychiatric dysfunction.

Entities:  

Mesh:

Year:  1991        PMID: 1848609     DOI: 10.1007/bf02599254

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  54 in total

1.  Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

Authors:  L J Bessen; J B Greene; E Louie; P Seitzman; H Weinberg
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

2.  Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.

Authors:  A M Sugar; C Saunders
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

Review 3.  Syphilis and HIV infection.

Authors:  E W Hook
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

4.  Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers.

Authors:  B Wong; J W Gold; A E Brown; M Lange; R Fried; M Grieco; D Mildvan; J Giron; M L Tapper; C W Lerner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

5.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

6.  Polymyositis associated with AIDS retrovirus.

Authors:  M C Dalakas; G H Pezeshkpour; M Gravell; J L Sever
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

7.  The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.

Authors:  J T Rutka; J R Giblin; M E Berens; E Bar-Shiva; K Tokuda; J R McCulloch; M L Rosenblum; T E Eessalu; B B Aggarwal; W J Bodell
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

8.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

9.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  2 in total

1.  Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia.

Authors:  G Arendt; H Hefter; E Neuen-Jacob; S Wist; H Kuhlmann; G Strohmeyer; H J Freund
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

2.  Evaluation of a brain-targeting zidovudine chemical delivery system in dogs.

Authors:  M E Brewster; W R Anderson; A I Webb; L M Pablo; D Meinsma; D Moreno; H Derendorf; N Bodor; E Pop
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.